Cefprozil: Difference between revisions

Jump to navigation Jump to search
Gerald Chi (talk | contribs)
m Changed protection level for "Cefprozil" ([Edit=Allow only autoconfirmed users] (expires 19:43, 14 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 19:43, 14 January 2014 (UTC)))
Abdurahman Khalil (talk | contribs)
No edit summary
Line 1: Line 1:
{{SI}}
__NOTOC__
{{CMG}}
{{Cefprozil}}
 
{{CMG}};{{AE}}{{AK}}




==Overview==
==Overview==
<small>'''''Synonyms:''''' Cefprozilo [INN-Spanish], Cefprozil anhydrous, Cefprozilum [INN-Latin]. </small>
'''''Synonyms:''''' Cefprozilo [INN-Spanish], Cefprozil anhydrous, Cefprozilum [INN-Latin]. A second generation [[Cephalosporins]] .It comes either tablet or powder for intravenous injection.
 
==Category==
<small>'''''Brand Names:''''' Arzimol, Brisoral, Cronocef, Procef, Serozil. </small>
[[Cephalosporins]],second generation.
==US Brand Names==
Cefzil<sup>®</sup>
==Dosing and Administration==
==Dosing and Administration==
Cefprozil tablets are administered orally.
Cefprozil tablets are administered orally.
===Adults (13 years and older)===
*Pharyngitis/Tonsillitis: 500 mg every 24h for 10 days.
*Acute sinusitis: 250 mg or 500 mg every 12h for 10 days.
*Secondary bacterial infection of acute bronchitis and acute bacterial exacerbation of chronic bronchitis: 500 mg every 12h for 10 days.
*Uncomplicated skin and skin structure infections: 250 mg every 12h for 10 days, 500 mg every 24h for 10 days, or 500 mg every 12h for 10 days.
<br>
===Children (2 years-12 years)===
*Pharyngitis/Tonsillitis: 7.5 mg/kg every 12h for 10 days.
*Uncomplicated skin and skin structure infections: 20 mg/kg every 24h for 10 days.
<br>
===Infants & children (6 months-12 years)===
*Otitis media: 15 mg/kg every 12h 10 days.
*Acute sinusitis: 7.5 mg/kg every 12h or 15 mg/kg every 12h for 10 days.
<br>
===Renal impairment===
*For patients with a creatinine clearance of 0-29 mL/min, administer 50% of the standard dosage in mg.
<br>
===Hepatic impairment===
*No dosage adjustment is necessary for patients with impaired hepatic function.
<br>
{{FDA}}


[[Category:Drugs]]
==FDA Package Insert==
'''  [[Cefprozil description|Description]]'''
'''| [[Cefprozil clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Cefprozil microbiology|Microbiology]]'''
'''| [[Cefprozil indications and usage|Indications and Usage]]'''
'''| [[Cefprozil contraindications|Contraindications]]'''
'''| [[Cefprozil warnings and precautions|Warnings and Precautions]]'''
'''| [[Cefprozil adverse reactions|Adverse Reactions]]'''
'''| [[Cefprozil overdosage|Overdosage]]'''
'''| [[Cefprozil clinical studies|Clinical Studies]]'''
'''| [[Cefprozil dosage and administration|Dosage and Administration]]'''
'''| [[Cefprozil Compatibility and Stability|Compatibility and Stability]]'''
'''| [[Cefprozil how supplied|How Supplied]]'''
'''| [[Cefprozil labels and packages|Labels and Packages]]'''

Revision as of 00:16, 2 January 2014

Cefprozil
CEFZIL®,CEFPROZIL® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
Clinical Studies
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]


Overview

Synonyms: Cefprozilo [INN-Spanish], Cefprozil anhydrous, Cefprozilum [INN-Latin]. A second generation Cephalosporins .It comes either tablet or powder for intravenous injection.

Category

Cephalosporins,second generation.

US Brand Names

Cefzil®

Dosing and Administration

Cefprozil tablets are administered orally.

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility and Stability | How Supplied | Labels and Packages